Translational research/biomarkers

2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial

Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.878 Susana Banerjee, T. André, D. Berton, S. Ellard, B. Jímenez, V. Samouëlian, L. Gilbert, V. Boni, Xinwei Han, G. Antony, J. Veneris, A. Oaknin

2022-RA-627-ESGO Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer

Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.868 Arturas Dobilas, P. Leandersson, Yilun Chen, M. Alcaide, C. Brueffer, L. Saal, C. Borgfeldt

2022-RA-1480-ESGO TRANSLACOL project: digital-PCR human papilloma virus (HPV) detection for recurrence prediction in early cervical cancer patients without pelvic lymph node invasion

Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.895 R. M. Macías, Nicolas Robillard, T. Bruneau, Coronado Pluvio, Mélanie Boulhic, M. L. Frére-Belda, I. Stanković, M. Ángeles, E. Mery, P. Rigolet, C. Badoual, P. Mathevet, A. Bats, V. Taly, D. Veyer, F. Lécuru, H. Péré